Chronic intestinal pseudo-obstruction due to intestinal neuronal dysplasia type B (IND B), concerning one case
DOI:
https://doi.org/10.23938/ASSN.0364Keywords:
Intestinal neuronal dysplasia B. Intestinal subocculsion.Abstract
Intestinal neuronal dysplasia type B (IND B) is an infrequent disease due to hyperplasia of the parasympathetic submucous plexus which causes alteration of intestinal motility, giving rise to symptoms of constipation and subocclusive manifestations. The disease is difficult to diagnose. It requires high clinical suspicion and should include differential diagnosis of patients with repeated subocclusive manifestations in order to make an early and correct diagnosis and avoid complications derived from unnecessary surgery that worsens the prognosis.
We present the case of a 33-year-old Moroccan male who was admitted to our hospital on 2 occasions in 11 months, requiring total parenteral nutrition (TPN) for five months. The immunohistochemical analysis of the ileostomy and colostomy stoma led to a diagnosis of IND B. Eighteen months later, the patients is leading a normal life and has recovered the 25 kilos lost following the dietary indications and with the enzymatic supplements.Downloads
References
1. MUÑOZ MT, SOLÍS HERRUZO JA. Pseudo-obstrucción intestinal crónica. Rev Esp Enferm Dig 2007; 99:100-111.
https://doi.org/10.4321/S1130-01082007000200008
2. MEIER-RUGE WA, BRUDER E, KAPUR RP. Intestinal neuronal dysplasia type B: one giant ganglion is not good enough. Pediatr Dev Pathol 2006; 9: 444-452.
https://doi.org/10.2350/06-06-0109.1
3. SOTO CASTILLO D, BANNURA CUMSILLE G, PEÑALOZA MONTECINOS P. Displasia neuronal intestinal como causa de constipación crónica pertinaz en adulto. Rev Chilena de Cirugía 2006; 58: 54-58.
https://doi.org/10.4067/S0718-40262006000100013
4. VIJAYARAGHAVAN R, CHANDRASHEKAR R, MELKOTE JYOTIPRAKASH A, KUMAR R, RASHMI MV, SHANMUKHAPPA BELAGAVI C. Intestinal neuronal dysplasia (type B) causing fatal small bowel ischaemia in an adult: a case report. Eur J Gastroenterol Hepatol 2006; 18: 773-776.
5. FERNÁNDEZ RM, SÁNCHEZ-MEJÍAS A, RUIZ-FERRER MM, LÓPEZ-ALONSO M, ANTIÑOLO G, BORREGO S. Is the RET proto-oncogene involved in the pathogenesis of intestinal neuronal dysplasia type B? Mol Med Report 2009; 2: 265-270.
6. SÁNCHEZ-MEJÍAS A, FERNÁNDEZ RM, ANTIÑOLO G, BORREGO S. A new experimental approach is required in the molecular analysis of intestinal neuronal dysplasia type B patients. Exp Ther Med 2010; 1: 999-1003.
https://doi.org/10.3892/etm.2010.140
7. JENG YM, MAO TL, HSU WM, HUANG SF, HSU HC. Congenital interstitial cell of cajal hyperplasia with neuronal intetsinal dysplasia. Am J Surg Pathol 2000; 24: 1568-1572.
https://doi.org/10.1097/00000478-200011000-00016
8. STANGHELLINI V, COGLIANDRO RF, DE GIORGIO R et al. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol 2005; 3: 449-458.
https://doi.org/10.1016/S1542-3565(04)00675-5
9. HAN EC, OH HK, HA HK, CHOE EK, MOON SH, RYOO SB et al. Favorable surgical treatment outcomes for chronic constipation with features of colonic psedo-obstruction. World J Gastroenterol 2012; 18: 4441-4446.
https://doi.org/10.3748/wjg.v18.i32.4441
10. CHOE EK, PARK SH, PARK KJ. Colonic pseudo-obstruction with distinct transitional zone in adult constipation patients: pathological analysis and results of surgical treatment. Am Surg 2011; 77: 736-742.
https://doi.org/10.1177/000313481107700630
11. SCHIMPL G, URAY E, RATSCHEK M, HÖLLWARTH ME. Constipation and intestinal neuronal dysplasia type B: a clinical follow-up study. J Pediatr Gastroenterol Nutr 2004; 38: 308-311.
https://doi.org/10.1002/j.1536-4801.2004.tb12168.x
12. STOSS F, MEIER-RUGE W. Experience with neuronal intestinal dysplasia (NID) in adults. Eur J Pediatr Surg 1994; 4: 298-302.
Additional Files
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.


